Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/eijjCrsecrAIfOqFNtJk

January 24, 2013
Sign upForwardArchive
News for the PBM Industry

  Featured Stories 
 Registration is now open for PCMA's Managed Markets Educational Forum!
Whether you are a seasoned managed markets executive or someone who supports the team, PCMA's Managed Markets Educational Forum will provide valuable education on fundamental, as well as complex and strategic issues relevant to professionals of all levels within pharma managed markets or market access divisions. Visit PCMA's website to learn more about our 2013 events!
 

  Legislative & Regulatory News 
  • States will embrace Medicaid expansion, insurance exec says
    Most states will eventually decide to expand Medicaid in accordance with the Affordable Care Act, WellPoint Executive Vice President Richard Zoretic says. Though eligibility and coverage vary among states, most have made efforts to improve the application process by allowing online enrollment and renewal, a Kaiser Family Foundation study shows. Reuters (1/23) LinkedInFacebookTwitterEmail this Story
  • NAIC president: Postpone health care law to avoid chaos
    Implementation of the Affordable Care Act might need to be delayed beyond the scheduled Oct. 1 start of enrollment in order to avoid chaos as millions of uninsured Americans begin using the system, says Jim Donelon, president of the National Association of Insurance Commissioners. "It's [President Barack Obama's] calling-card, signature issue, and to rush it into implementation before it's ready would not be in his overall interest," Donelon says. Bloomberg (1/22) LinkedInFacebookTwitterEmail this Story
  Drug Industry Spotlight 
  • FDA: Low prices contribute to generic drug shortages
    Competition within the generic drug market that keeps prices low also contributes to injectable drug shortages, an FDA report says. Generics manufacturers may try to keep their costs low by cutting corners on quality control, and few generics makers have backup manufacturing facilities available in the event that quality issues halt production, FDA officials said. The Medicare Modernization Act of 2005 lowered reimbursement rates for generic sterile injectable drugs and might have had a role in shortages, they said. MedPage Today (free registration) (1/23) LinkedInFacebookTwitterEmail this Story
  SmartQuote 
All news is an exaggeration of life."
--Daniel Schorr,
American journalist


LinkedInFacebookTwitter

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

 
Contact PCMA
Charles Cote
Assistant Vice President, Strategic Communications
(202) 207-3610

Twitter  Follow PCMA on Twitter
 
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

 
 Recent PCMA SmartBrief Issues:   Lead Editor:  Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information